Florida Surgeon General Joseph Ladapo on Tuesday accused the Biden administration of actively blocking the sending of monoclonal antibody treatments for COVID-19 patients to Florida, according to a letter he sent to Secretary of Health and Human Services (HHS) Xavier Becerra. Both HHS and the Food and Drug Administration (FDA) announced in September the federal government would pause the distribution of antibody therapies manufactured by Regeneron and Eli Lily. The White House still supplies Sotrovimab, a monoclonal antibody from Glaxosmithkline, which reportedly works against the Omicron variant. But Ladapo, who was appointed by Florida Gov. Ron DeSantis several months ago, contended that “federal agencies under your control should not limit our state’s access to any available treatment for COVID-19,” according to his letter to Becerra. “Florida can expand treatment options for patients by distributing therapeutics to providers working in areas with a low prevalence of Omicron or clinics capable of variant screening,” his …